These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis. Lefvert AK; Pirskanen R; Svanborg E J Neuroimmunol; 1985 Jul; 9(1-2):41-53. PubMed ID: 4008636 [TBL] [Abstract][Full Text] [Related]
28. A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy. Grinlinton FM; Lynch NM; Hart HH Arthritis Rheum; 1991 Jul; 34(7):916-9. PubMed ID: 2059238 [TBL] [Abstract][Full Text] [Related]
30. Cellular production of antibodies related to the acetylcholine receptor in myasthenia gravis: correlation with clinical stage. Lefvert AK; Holm G; Sundén H; Pirskanen R Scand J Immunol; 1987 Mar; 25(3):265-73. PubMed ID: 2436288 [TBL] [Abstract][Full Text] [Related]
31. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia. Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665 [TBL] [Abstract][Full Text] [Related]
33. Antibodies against the acetylcholine receptor also in nonmyasthenic autoimmune disease. Sundewall AC; Lefvert K Ann N Y Acad Sci; 1988; 540():525-7. PubMed ID: 3207283 [No Abstract] [Full Text] [Related]
34. T cells with specificity for idiotypic determinants on human monoclonal autoantibodies in myasthenia gravis. Yi Q; Ahlberg R; Lefvert AK Res Immunol; 1992 Feb; 143(2):149-56. PubMed ID: 1574640 [TBL] [Abstract][Full Text] [Related]
35. Familial occurrence of autoimmune myasthenia gravis with different antibody specificity. Lavrnic D; Nikolic A; De Baets M; Verschuuren J; Verduyn W; Losen M; Stojanovic V; Stevic Z; Hajdukovic Lj; Apostolski S Neurology; 2008 May; 70(21):2011-3. PubMed ID: 18490624 [No Abstract] [Full Text] [Related]
36. Myasthenia gravis in monozygotic twins. Clinical follow-up nine years after thymectomy. Allen N; Kissel P; Pietrasiuk D; Perlow MJ Arch Neurol; 1984 Sep; 41(9):994-6. PubMed ID: 6541031 [TBL] [Abstract][Full Text] [Related]
37. Strategies for the treatment of myasthenia gravis. Drachman DB; McIntosh KR; De Silva S; Kuncl RW; Kahn C Ann N Y Acad Sci; 1988; 540():176-86. PubMed ID: 2849890 [No Abstract] [Full Text] [Related]
38. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis. Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656 [TBL] [Abstract][Full Text] [Related]
39. The auto-anti-idiotypic route to antireceptor antibodies. Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Wan KK; Sarangarajan R; Penn AS Ann N Y Acad Sci; 1986; 475():219-26. PubMed ID: 3491562 [No Abstract] [Full Text] [Related]
40. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction. Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]